Executive Director and Chief Executive Officer, AstraZeneca. Formerly with Roche/Genentech: Chief Operating Officer, Pharmaceuticals Division, Chief Executive Officer of Genentech; led successful merger with Roche, Head of Commercial Operations, Head of Strategic Marketing. With Aventis/Sanofi Aventis: Chief Operating Officer of Aventis/Sanofi Aventis USA, Head of Global Marketing and Medical Affairs, Aventis. Other previous positions: finance, sales, marketing, and general management positions for Roussel and Hoechst Marion Roussel in Asia-Pacific. Doctor of Veterinary Medicine from École nationale vétérinaire d’Alfort, Maisons-Alfort; MBA from HEC, Paris.
Eighteen months ago, when the COVID-19 pandemic’s grip on the world began to take hold, AstraZeneca recognised the urgent need to develop a vaccine to defeat the novel coronavirus. Today,...
Over the past fortnight, tens of millions of doses of the AstraZeneca/Oxford COVID-19 vaccine have been landing at airports around the world through the multilateral COVAX initiative.
